These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 9501459

  • 1. Synthesis, antimuscarinic activity and quantitative structure-activity relationship (QSAR) of tropinyl and piperidinyl esters.
    Xu R, Sim MK, Go ML.
    Chem Pharm Bull (Tokyo); 1998 Feb; 46(2):231-41. PubMed ID: 9501459
    [Abstract] [Full Text] [Related]

  • 2. M3/M1-Selective antimuscarinic tropinyl and piperidinyl esters.
    Xu R, Sim MK, Go ML.
    Eur J Pharm Sci; 1999 Apr; 8(1):39-47. PubMed ID: 10072477
    [Abstract] [Full Text] [Related]

  • 3. Novel imidazole derivatives with subtype-selective antimuscarinic activity (2).
    Miyachi H, Kiyota H, Segawa M.
    Bioorg Med Chem Lett; 1998 Aug 18; 8(16):2163-8. PubMed ID: 9873506
    [Abstract] [Full Text] [Related]

  • 4. Design and synthesis of piperidinyl piperidine analogues as potent and selective M2 muscarinic receptor antagonists.
    Wang Y, Chackalamannil S, Hu Z, Clader JW, Greenlee W, Billard W, Binch H, Crosby G, Ruperto V, Duffy RA, McQuade R, Lachowicz JE.
    Bioorg Med Chem Lett; 2000 Oct 16; 10(20):2247-50. PubMed ID: 11055330
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Low concentrations of pyridostigmine prevent soman-induced inhibition of GABAergic transmission in the central nervous system: involvement of muscarinic receptors.
    Santos MD, Pereira EF, Aracava Y, Castro NG, Fawcett WP, Randall WR, Albuquerque EX.
    J Pharmacol Exp Ther; 2003 Jan 16; 304(1):254-65. PubMed ID: 12490599
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis, muscarinic blocking activity and molecular modeling studies of 4-DAMP-related compounds.
    Recanatini M, Tumiatti V, Budriesi R, Chiarini A, Sabatino P, Bolognesi ML, Melchiorre C.
    Bioorg Med Chem; 1995 Mar 16; 3(3):267-77. PubMed ID: 7606388
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis and antimuscarinic activity of some ether- and thioether-bearing 1,3-dioxolanes and related sulfoxides and sulfones.
    Malmusi L, Franchini S, Mucci A, Schenetti L, Gulini U, Marucci G, Brasili L.
    Bioorg Med Chem; 1998 Jun 16; 6(6):825-32. PubMed ID: 9681148
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Design, synthesis, and structure-activity relationship of tropane muscarinic acetylcholine receptor antagonists.
    Lainé DI, Wan Z, Yan H, Zhu C, Xie H, Fu W, Busch-Petersen J, Neipp C, Davis R, Widdowson KL, Blaney FE, Foley J, Bacon AM, Webb EF, Luttmann MA, Burman M, Sarau HM, Salmon M, Palovich MR, Belmonte K.
    J Med Chem; 2009 Aug 27; 52(16):5241-52. PubMed ID: 19630384
    [Abstract] [Full Text] [Related]

  • 17. Diphenylsulfone muscarinic antagonists: piperidine derivatives with high M2 selectivity and improved potency.
    Billard W, Binch H, Bratzler K, Chen LY, Crosby G, Duffy RA, Dugar S, Lachowicz J, McQuade R, Pushpavanam P, Ruperto VB, Taylor LA, Clader JW.
    Bioorg Med Chem Lett; 2000 Oct 02; 10(19):2209-12. PubMed ID: 11012031
    [Abstract] [Full Text] [Related]

  • 18. Selective muscarinic antagonists. I. Synthesis and antimuscarinic properties of 4-piperidyl benzhydrylcarbamate derivatives.
    Naito R, Takeuchi M, Morihira K, Hayakawa M, Ikeda K, Shibanuma T, Isomura Y.
    Chem Pharm Bull (Tokyo); 1998 Aug 02; 46(8):1274-85. PubMed ID: 9734315
    [Abstract] [Full Text] [Related]

  • 19. Selective muscarinic antagonists. II. Synthesis and antimuscarinic properties of biphenylylcarbamate derivatives.
    Naito R, Takeuchi M, Morihira K, Hayakawa M, Ikeda K, Shibanuma T, Isomura Y.
    Chem Pharm Bull (Tokyo); 1998 Aug 02; 46(8):1286-94. PubMed ID: 9734316
    [Abstract] [Full Text] [Related]

  • 20. A potent, long-acting, orally active (2R)-2-[(1R)-3, 3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: novel muscarinic M(3) receptor antagonist with high selectivity for M(3) over M(2) receptors.
    Mitsuya M, Kobayashi K, Kawakami K, Satoh A, Ogino Y, Kakikawa T, Ohtake N, Kimura T, Hirose H, Sato A, Numazawa T, Hasegawa T, Noguchi K, Mase T.
    J Med Chem; 2000 Dec 28; 43(26):5017-29. PubMed ID: 11150173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.